BioCentury
ARTICLE | Clinical News

Aironite: Phase II data

September 15, 2014 7:00 AM UTC

Top-line data from the open-label, international Phase II AIR001-CS05 trial in 29 patients with PAH showed that all doses of AIR001 improved median PVR, the primary endpoint, and 6MWD, a secondary end...